Bionic Power
Bionic Power’s purpose is to design and develop lower-body smart orthoses that improve quality of life by enhancing personal mobility and walking abilities. Bionic Power Inc. is a Canadian, privately held company that has developed and holds IP rights on wearable technology. This technology addresses the rapidly growing market for mobility assistance in patients with knee pathologies and both military and consumer use for endurance enhancement. Our Agilik medical device targets pediatric patients with crouch gait due to various pathologies such as cerebral palsy, spina bifida, muscular dystrophy and other knee-extension-deficiency disorders whose strength and endurance often deteriorate as they get older.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | CAD5.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Bionic Power Inc. operates within the medical device and assistive technology sector, focusing on enhancing human mobility through lower-body smart orthoses. Founded in 2007 by Dr. Max Donelan, an associate professor at Simon Fraser University, the company originated from his research into biomechanics and energy harvesting. The initial concept revolved around developing a device that could harvest energy from the natural motion of walking, a project that garnered early support from the Canadian military and government agencies looking for wearable power solutions for soldiers in the field.
Over time, the company's focus pivoted from purely military energy-harvesting applications to the broader healthcare market. This strategic shift led to the development of the Agilik™ smart orthosis, a wearable robotic device designed to assist individuals with mobility challenges. The Agilik™ targets patients, including children and adults, who suffer from knee-extension or flexion deficiencies. These conditions are often the result of cerebral palsy, spina bifida, stroke-induced hemiparesis, or other neurological disorders. The device functions by providing precisely timed assistance or resistance to knee movement throughout the walking cycle, aiming to correct gait patterns like crouch gait and stiff knee gait. By doing so, it helps strengthen the user's leg muscles, improve endurance, and enhance overall walking ability, potentially delaying or preventing the loss of mobility in adulthood for adolescent users.
The business model appears to be centered on the development and sale of this specialized medical device. Bionic Power likely generates revenue through direct sales to medical institutions, rehabilitation centers, and directly to patients through prescriptions. The target market includes a specific segment of the population with neuromuscular conditions affecting their gait. The company's journey reflects a transition from a research-driven energy-harvesting concept to a product-focused medical device company, backed by years of development, clinical trials, and funding from various sources including government grants and venture capital. The Agilik™ orthosis represents the core of its commercial efforts, positioning Bionic Power as a specialized player in the powered exoskeleton and smart orthotics market.
Keywords: smart orthosis, medical device, mobility assistance, biomechanics, assistive technology, cerebral palsy, stroke rehabilitation, wearable robotics, gait correction, neurorehabilitation